Trials / Completed
CompletedNCT00928655
Continuous Positive Airway Pressure and Acetazolamide to Treat Sleep Apnea Syndrome Patients at Altitude
Continuous Positive Airway Pressure (CPAP) and Acetazolamide for Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate the effect of nasal continuous positive airway pressure in combination with acetazolamide as a treatment for sleep related breathing disturbances in patients with the obstructive sleep apnea syndrome living at low altitude during a sojourn at moderate altitude.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | acetazolamide | acetazolamide 250mg 1/0/2 |
| PROCEDURE | nocturnal continuous positive airway pressure | continuous positive airway pressure |
| DRUG | placebo | placebo capsules |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2009-06-26
- Last updated
- 2014-05-20
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00928655. Inclusion in this directory is not an endorsement.